N-benzyl-3,4-di-O-benzyl-2-C-benzyloxymethyl-6-O-tert-butyldimethylsilyl-1,2,5-trideoxy-1,5-imino-D-glucitol | 682771-66-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-benzyl-3,4-di-O-benzyl-2-C-benzyloxymethyl-6-O-tert-butyldimethylsilyl-1,2,5-trideoxy-1,5-imino-D-glucitol
• CAS: 682771-66-0
• 化学式: C₄₁H₅₃NO₄Si
• 分子量: 651.962
• InChiKey: LRYILLIJUPEFJP-JUFVCXMFSA-N

物化性质

• 沸点：
  668.0±55.0 °C(Predicted)
• 密度：
  1.09±0.1 g/cm3(Predicted)

反应信息

• 作为反应物：
  描述：

  N-benzyl-3,4-di-O-benzyl-2-C-benzyloxymethyl-6-O-tert-butyldimethylsilyl-1,2,5-trideoxy-1,5-imino-D-glucitol 在 palladium on activated charcoal sodium azide 、 四丁基氟化铵 、 水 、 氢气 、 甲基磺酰氯 、 三乙胺 、 三苯基膦 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 41.25h， 生成 N-((2R,3R,4R,5R)-3,4-Dihydroxy-5-hydroxymethyl-piperidin-2-ylmethyl)-acetamide
  参考文献：
  名称：

  Design and synthesis of 2-acetamidomethyl derivatives of isofagomine as potential inhibitors of human lysosomal β-hexosaminidases

  摘要：

  As part of a program towards the development of specific inhibitors of human lysosomal beta-hexosaminidase for use as chemical chaperones in therapy of G(M2) gangliosidosis related diseases, the synthesis of 2-acetamidomethyl derivatives of isofagomine has been undertaken. Key event in this synthesis is the conversion of a C-2 substituted gluconolactone derivative into the corresponding lactam, followed by reduction to the corresponding amine. The 1-N-imino-2 acetamidomethyl derivative 5 proved to be a rather selective inhibitor with a K-i of 2.4 muM for homogenate of human spleen lysosomal beta-hexosaminidase. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2003.12.040
• 作为产物：
  描述：

  3,4-di-O-benzyl-2-C-benzyloxymethyl-6-O-tert-butyldimethylsilyl-2-deoxy-D-gluco-δ-lactam 在 dimethyl sulfide borane 、 三乙胺 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 32.0h， 生成 N-benzyl-3,4-di-O-benzyl-2-C-benzyloxymethyl-6-O-tert-butyldimethylsilyl-1,2,5-trideoxy-1,5-imino-D-glucitol
  参考文献：
  名称：

  Design and synthesis of 2-acetamidomethyl derivatives of isofagomine as potential inhibitors of human lysosomal β-hexosaminidases

  摘要：

  As part of a program towards the development of specific inhibitors of human lysosomal beta-hexosaminidase for use as chemical chaperones in therapy of G(M2) gangliosidosis related diseases, the synthesis of 2-acetamidomethyl derivatives of isofagomine has been undertaken. Key event in this synthesis is the conversion of a C-2 substituted gluconolactone derivative into the corresponding lactam, followed by reduction to the corresponding amine. The 1-N-imino-2 acetamidomethyl derivative 5 proved to be a rather selective inhibitor with a K-i of 2.4 muM for homogenate of human spleen lysosomal beta-hexosaminidase. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2003.12.040